 |
FliC Flagellin Deletion Variant TLR5 Agonist |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of death following a potentially lethal dose of total body irradiation during or after a radiation disaster |
| USA Market Approval | USA |
| USA Designation Date | 2010-11-23 00:00:00 |
| Sponsor | Cleveland BioLabs, Inc.;73 High Street;Buffalo, New York, 14203 |
